Panagora Asset Management Inc Catalyst Biosciences, Inc. Transaction History

Panagora Asset Management Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$4.1 - $5.33 $17,765 - $23,094	-4,333 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$4.93 - $7.15 $16,170 - $23,452	3,280 Added 311.49%	4,333 $22,000
Q4 2020 Feb 10, 2021	SELL	$4.55 - $7.29 $54,631 - $87,531	-12,007 Reduced 91.94%	1,053 $7,000
Q3 2020 Nov 13, 2020	BUY	$4.22 - $6.04 $1,367 - $1,956	324 Added 2.54%	13,060 $56,000
Q2 2020 Aug 12, 2020	BUY	$3.76 - $8.01 $47,887 - $102,015	12,736 New	12,736 $75,000
Q2 2019 Aug 09, 2019	SELL	$7.08 - $10.6 $417 - $625	-59 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$7.67 - $9.96 $153 - $199	-20 Reduced 25.32%	59 $0
Q4 2018 Feb 14, 2019	BUY	$6.59 - $11.28 $131 - $225	20 Added 33.9%	79 $1,000
Q3 2018 Nov 13, 2018	SELL	$9.35 - $12.44 $174,293 - $231,894	-18,641 Reduced 99.68%	59 $1,000
Q2 2018 Aug 14, 2018	BUY	$9.11 - $28.88 $169,819 - $538,352	18,641 Added 31594.92%	18,700 $218,000
Q3 2017 Nov 14, 2017	BUY	$3.19 - $5.1 $188 - $300	59	59 $0

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.